Z-DNA binding proteins as targets for structure-based virtual screening

Current Drug Targets

Volumn 11, Issue 3, 2010, Pages 335-344

  Kim, Doyoun ^a   Lee, Young Ho ^b   Hwang, Hye Yeon ^a   Kim, Kyeong Kyu ^a   Park, Hyun Ju ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

ADAR1; Computer aided drug design; DAI (DLM 1 ZBP1); E3L; PKZ; Scoring function; Virtual screening; Z domain; Z domain; Z DNA; Z DNA binding protein

Indexed keywords

ADAR1 PROTEIN; BINDING PROTEIN; DLM 1 PROTEIN; DNA Z; E3L PROTEIN; IMATINIB; PKZ PROTEIN; RETINOIC ACID RECEPTOR; RNA BINDING PROTEIN; SILDENAFIL; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; COMPUTER AIDED DESIGN; COMPUTER MODEL; CRYSTAL STRUCTURE; DRUG TARGETING; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN INTERACTION; PROTEIN TARGETING; SCREENING; VACCINIA VIRUS; VIRTUAL REALITY;

ANIMALS; COMPUTER-AIDED DESIGN; DNA, Z-FORM; DNA-BINDING PROTEINS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; IMMUNE SYSTEM DISEASES; INFECTION; PROTEIN BINDING;

EID: 77950816797     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945010790711905     Document Type: Article

References (85)

1. Wang AH, Quigley GJ, Kolpak FJ, et al. Molecular structure of a left-handed double helical DNA fragment at atomic resolution. Nature 1979; 282(5740): 680-686
2. Pohl FM, Jovin TM. Salt-induced co-operative conformational change of a synthetic DNA: equilibrium and kinetic studies with poly (dG-dC). J Mol Biol 1972; 67(3): 375-396
3. Thamann TJ, Lord RC, Wang AH, Rich A. The high salt form of poly(dG-dC).poly(dG-dC) is left-handed Z-DNA: Raman spectra of crystals and solutions. Nucleic Acids Res 1981; 9(20): 5443-5457
4. Haschemeyer AE, Rich A. Nucleoside conformations: an analysis of steric barriers to rotation about the glycosidic bond. J Mol Biol 1967; 27(2): 369-384
5. Davies DB. Conformations of nucleosides and nucleotides Prog Nucl Mag Res Spectrosc 1978; 12(3): 135-225.
6. Kadalayil LP, Majumder K, Mishra RK, Brahmachari SK. Sequence specificity of Z-DNA formation in oligonucleotides. Biochem Int 1988; 17(1): 121-131
7. Klump HH, Schmid E, Wosgien M. Energetics of Z-DNA formation in poly d(A-T), poly d(G-C), and poly d(A-C) poly d(GT). Nucleic Acids Res 1993; 21(10): 2343-2348
8. Peck LJ, Nordheim A, Rich A, Wang JC. Flipping of cloned d(pCpG)n.d(pCpG)n DNA sequences from right- to left-handed helical structure by salt, Co(III), or negative supercoiling. Proc Natl Acad Sci USA 1982; 79(15): 4560-4564
9. Feigon J, Wang AH, van der Marel GA, van Boom JH, Rich A. ZDNA forms without an alternating purine-pyrimidine sequence in solution. Science 1985; 230(4721): 82-84 (Pubitemid 16221622)
10. Ha SC, Choi J, Hwang HY, Rich A, Kim YG, Kim KK. The structures of non-CG-repeat Z-DNAs co-crystallized with the Z-DNA-binding domain, hZ (ADAR1). Nucleic Acids Res 2009; 37(2): 629-637
11. Moller A, Nordheim A, Kozlowski SA, Patel DJ, Rich A. Bromination stabilizes poly(dG-dC) in the Z-DNA form under low-salt conditions. Biochemistry 1984; 23(1): 54-62.
12. Behe M, Felsenfeld G. Effects of methylation on a synthetic polynucleotide: the B-Z transition in poly(dG-m5dC).poly(dG-m5dC). Proc Natl Acad Sci USA 1981; 78(3): 1619-1623
13. Gessner RV, Quigley GJ, Wang AH, van der Marel GA, van Boom JH, Rich A. Structural basis for stabilization of Z-DNA by cobalt hexaammine and magnesium cations. Biochemistry 1985; 24(2): 237-240
14. Lafer EM, Valle RP, Moller A, et al. Z-DNA-specific antibodies in human systemic lupus erythematosus. J Clin Invest 1983; 71(2): 314-321
15. Nordheim A, Pardue ML, Lafer EM, Moller A, Stollar BD, Rich A. Antibodies to left-handed Z-DNA bind to interband regions of Drosophila polytene chromosomes. Nature 1981; 294(5840): 417-422 (Pubitemid 12220246)
16. Wittig B, Wolfl S, Dorbic T, Vahrson W, Rich A. Transcription of human c-myc in permeabilized nuclei is associated with formation of Z-DNA in three discrete regions of the gene. EMBO J 1992; 11(12): 4653-4663
17. Liu LF, Wang JC. Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 1987; 84(20): 7024-7027
18. Singleton CK, Klysik J, Stirdivant SM, Wells RD. Left-handed ZDNA is induced by supercoiling in physiological ionic conditions. Nature 1982; 299(5881): 312-316 (Pubitemid 12012856)
19. Ho PS, Ellison MJ, Quigley GJ, Rich A. A computer aided thermodynamic approach for predicting the formation of Z-DNA in naturally occurring sequences. EMBO J 1986; 5(10): 2737-2744
20. Schroth GP, Chou PJ, Ho PS. Mapping Z-DNA in the human genome. Computer-aided mapping reveals a nonrandom distribution of potential Z-DNA-forming sequences in human genes. J Biol Chem 1992; 267(17): 11846-11855
21. Oh DB, Kim YG, Rich A. Z-DNA-binding proteins can act as potent effectors of gene expression in vivo. Proc Natl Acad Sci USA 2002; 99(26): 16666-16671 (Pubitemid 36034030)
22. Rothenburg S, Koch-Nolte F, Rich A, Haag F. A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity. Proc Natl Acad Sci USA 2001; 98(16): 8985-8990 (Pubitemid 32743856)
23. Liu R, Liu H, Chen X, Kirby M, Brown PO, Zhao K. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 2001; 106(3): 309-318 (Pubitemid 32772615)
24. Wong B, Chen S, Kwon JA, Rich A. Characterization of Z-DNA as a nucleosome-boundary element in yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2007; 104(7): 2229-2234
25. Wang G, Vasquez KM. Non-B DNA structure-induced genetic instability. Mutat Res 2006; 598(1-2): 103-119
26. Wang G, Christensen LA, Vasquez KM. Z-DNA-forming sequences generate large-scale deletions in mammalian cells. Proc Natl Acad Sci USA 2006; 103(8): 2677-2682
27. Li H, Xiao J, Li J, Lu L, Feng S, Droge P. Human genomic Z-DNA segments probed by the Z domain of ADAR1. Nucleic Acids Res 2009; 37(8): 2737-2746
28. Herbert AG, Rich A. A method to identify and characterize Z-DNA binding proteins using a linear oligodeoxynucleotide. Nucleic Acids Res 1993; 21(11): 2669-2672
29. Rich A, Zhang S. Timeline: Z-DNA: the long road to biological function. Nat Rev Genet 2003; 4(7): 566-572
30. Herbert A, Alfken J, Kim YG, Mian IS, Nishikura K, Rich A. A ZDNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proc Natl Acad Sci USA 1997; 94(16): 8421-8426
31. Schwartz T, Behlke J, Lowenhaupt K, Heinemann U, Rich A. Structure of the DLM-1-Z-DNA complex reveals a conserved family of Z-DNA-binding proteins. Nat Struct Biol 2001; 8(9): 761-765
32. Rothenburg S, Deigendesch N, Dittmar K, et al. A PKR-like eukaryotic initiation factor 2 kinase from zebrafish contains ZDNA binding domains instead of dsRNA binding domains. Proc Natl Acad Sci USA 2005; 102(5): 1602-1607
33. Ha SC, Lokanath NK, Van Quyen D, et al. A poxvirus protein forms a complex with left-handed Z-DNA: crystal structure of a Yatapoxvirus Z bound to DNA. Proc Natl Acad Sci USA 2004; 101(40): 14367-14372
34. Berger I, Winston W, Manoharan R, et al. Spectroscopic characterization of a DNA-binding domain, Z alpha, from the editing enzyme, dsRNA adenosine deaminase: evidence for left-handed Z-DNA in the Z alpha-DNA complex. Biochem 1998; 37(38): 13313-13321
35. Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995; 15(10): 5376-5388
36. Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004; 279(6): 4894-4902
37. Wang Q, Miyakoda M, Yang W, et al. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004; 279(6): 4952-4961
38. Kahmann JD, Wecking DA, Putter V, et al. The solution structure of the N-terminal domain of E3L shows a tyrosine conformation that may explain its reduced affinity to Z-DNA in vitro. Proc Natl Acad Sci USA; 101(9): 2712-2717
39. Chang HW, Jacobs BL. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 1993; 194(2): 537-547 (Pubitemid 23192848)
40. Chang HW, Uribe LH, Jacobs BL. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J Virol 1995; 69(10): 6605-6608
41. Kim YG, Muralinath M, Brandt T, et al. A role for Z-DNA binding in vaccinia virus pathogenesis. Proc Natl Acad Sci USA 2003; 100(12): 6974-6979 (Pubitemid 36706378)
42. Myskiw C, Arsenio J, van Bruggen R, Deschambault Y, Cao J. Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol 2009; 83(13): 6757-6768
43. Kwon JA, Rich A. Biological function of the vaccinia virus Z-DNA-binding protein E3L: gene transactivation and antiapoptotic activity in HeLa cells. Proc Natl Acad Sci USA 2005; 102(36): 12759-12764
44. Fu Y, Comella N, Tognazzi K, Brown LF, Dvorak HF, Kocher O. Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene 1999; 240(1): 157-163
45. Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448(7152): 501-505
46. Wang Z, Choi MK, Ban T, et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 2008; 105(14): 5477-5482 (Pubitemid 351753888)
47. Rebsamen M, Heinz LX, Meylan E, et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-κB. EMBO Rep 2009; 10(8): 916-922
48. Bergan V, Jagus R, Lauksund S, Kileng O, Robertsen B. The Atlantic salmon Z-DNA binding protein kinase phosphorylates translation initiation factor 2 and constitutes a unique orthologue to the mammalian dsRNA-activated protein kinase R. FEBS J 2008; 275(1): 184-197 (Pubitemid 350294074)
49. Hu CY, Zhang YB, Huang GP, Zhang QY, Gui JF. Molecular cloning and characterisation of a fish PKR-like gene from cultured CAB cells induced by UV-inactivated virus. Fish Shellfish Immunol 2004; 17(4): 353-366
50. Su J, Zhu Z, Wang Y. Molecular cloning, characterization and expression analysis of the PKZ gene in rare minnow Gobiocypris rarus. Fish Shellfish Immunol 2008; 25(1-2): 106-113
51. Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007; 89(6-7): 799-811.
52. Schwartz T, Rould MA, Lowenhaupt K, Herbert A, Rich A. Crystal structure of the Z domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science 1999; 284(5421): 1841-1845
53. Ha SC, Kim D, Hwang HY, Rich A, Kim YG, Kim KK. The crystal structure of the second Z-DNA binding domain of human DAI (ZBP1) in complex with Z-DNA reveals an unusual binding mode to Z-DNA. Proc Natl Acad Sci USA 2008; 105(52): 20671-20676
54. Kim YG, Lowenhaupt K, Oh DB, Kim KK, Rich A. Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo: Implications for development of a therapy for poxvirus infection. Proc Natl Acad Sci USA 2004; 101(6): 1514-1518
55. Jiang N, Pisetsky DS. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J Leukoc Biol 2005; 77(3): 296-302.
56. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006; 5(6): 471-484
57. Schneider G, Baringhaus KH. Molecular designs: Concepts and applications. Willey-VCH: Weinheim 2008: pp. 1-277.
58. Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today 2006; 11(13-14): 580-594 (Pubitemid 43912502)
59. Congreve M, Murray CW, Blundell TL. Structural biology and drug discovery. Drug Discov Today 2005; 10(13): 895-907.
60. Carr RA, Congreve M, Murray CW, Rees DC. Fragment-based lead discovery: leads by design. Drug Discov Today 2005; 10(14): 987-992 (Pubitemid 40967047)
61. Bleicher KH, Bohm HJ, Muller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2003; 2(5): 369-378 (Pubitemid 37361707)
62. Albert JS, Blomberg N, Breeze AL, et al. An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca's drug discovery programmes. Curr Top Med Chem 2007; 7(16): 1600-1629 (Pubitemid 350131017)
63. Koehn FE. High impact technologies for natural products screening. Prog Drug Res 2008; 65: 177-210.
64. Mohan V, Gibbs AC, Cummings MD, Jaeger EP, DesJarlais RL. Docking: successes and challenges. Curr Pharm Des 2005; 11(3): 323-333
65. Rester U. Dock around the clock - current status of small molecule docking and scoring. QSAR Comb Sci 2006; 25: 605-615 (Pubitemid 44121050)
66. Borman S. Drugs by design. Chem Eng News 2005; 83: 28-30.
67. Zoete V, Grosdidier A, Michielin O. Docking, virtual high throughput screening and in silico fragment-based drug design. J Cell Mol Med 2009; 13(2): 238-248
68. Olson AJ, Goodsell DS. Automated docking and the search for HIV protease inhibitors. SAR QSAR Environ Res 1998; 8(3-4): 273-285
69. O'Dwyer ME, Mauro MJ, Druker BJ. STI571 as a targeted therapy for CML. Cancer Invest 2003; 21(3): 429-438
70. Schapira M, Raaka BM, Samuels HH, Abagyan R. In silico discovery of novel retinoic acid receptor agonist structures. BMC Struct Biol 2001; 1: 1.
71. Abagyan R, Totrov M. High-throughput docking for lead generation. Curr Opin Chem Biol 2001; 5(4): 375-382
72. Martin YC. 3D database searching in drug design. J Med Chem 1992; 35(12): 2145-2154
73. th ed; SYBYL molecular modeling software, (http://www.tripos.com). Tripos Inc: St Louis, MO. 2003.
74. Marriott DP, Dougall IG, Meghani P, Liu YJ, Flower DR. Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists. J Med Chem 1999; 42(17): 3210-3216
75. Bissantz C, Folkers G, Rognan D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem 2000; 43(25): 4759-4767
76. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996; 261(3): 470-489 (Pubitemid 26335901)
77. Ewing TJ, Makino S, Skillman AG, Kuntz ID. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des 2001; 15(5): 411-428 (Pubitemid 32452109)
78. Ewing TJ, Kuntz ID. Critical evaluation of search algorithms for automated molecular docking and data base screening. J Comput Chem 1997; 18(9): 1175-1189
79. Bohm G. New approaches in molecular structure prediction. Biophys Chem 1996; 59(1-2): 1-32. (Pubitemid 26083132)
80. Glen RC, Allen SC. Ligand-protein docking: cancer research at the interface between biology and chemistry. Curr Med Chem 2003; 10(9): 763-767
81. Gohlke H, Klebe G. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. Angew Chem Int Ed Engl 2002; 41(15): 2644-2676
82. Wang R, Wang S. How does consensus scoring work for virtual library screening? An idealized computer experiment. J Chem Inf Comput Sci 2001; 41(5): 1422-1426 (Pubitemid 33663908)
83. Kim YG, Thai KM, Song J, Kim KK, Park HJ. Identification of novel ligands for the Z-DNA binding protein by structure-based virtual screening. Chem Pharm Bull (Tokyo) 2007; 55(2): 340-342 (Pubitemid 46246832)
84. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Exprimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997; 23(1-3): 3-25. (Pubitemid 27046991)
85. Roden LD, Myszka DG. Global analysis of a macromolecular interaction measured on BIAcore. Biochem Biophys Res Commun 1996; 225(3): 1073-1077